BML-111 is widely used in research for its potent anti-inflammatory and pro-resolving properties. It acts as a lipoxin A4 receptor agonist, helping to reduce inflammation by inhibiting the production of pro-inflammatory cytokines and suppressing neutrophil infiltration. This makes it valuable in studying inflammatory diseases such as arthritis, colitis, and lung injury. It has also shown protective effects in models of organ injury, including liver and kidney damage, by modulating oxidative stress and apoptosis. In addition, BML-111 is investigated for its role in promoting tissue repair and resolving infection-induced inflammation without suppressing the entire immune response, highlighting its potential as a targeted therapeutic agent in chronic inflammatory conditions.